Jim Kostka
VP, U.S Clinical Operations
Jim brings approximately 30 years of global clinical development experience covering all phases in the oncologic and rare disease space in both the Pharmaceutical/Biotech and CRO industries. Prior to joining Biodexa Pharmaceuticals, Jim served as the SVP Clinical Operations at SystImmune where he led the operational strategy of SystImmune’s ADC portfolio. Jim has been involved in all facets of global clinical research and development including clinical and regulatory development strategies including multiple NDA submissions which lead to successful drug approvals.
Jim holds Bachelor and Masters degrees in Biomedical Sciences.
